BrP-LPA sodium
BrP-LPA sodium is a broad-spectrum antagonist of lysophosphatidic acid (LPA), demonstrating antagonistic activity towards LPA1 (IC50 = 4520 nM), LPA2 (IC50 = 468 nM), LPA3, and LPA4. Additionally, BrP-LPA sodium exhibits partial agonistic activity at LPA5 with an EC50 of 1282 nM. It also acts as an ATX inhibitor and effectively inhibits the migration and invasion of breast cancer cells. In mouse xenograft models of breast cancer, BrP-LPA sodium induces tumor regression and anti-angiogenic effects. This compound is applicable for breast cancer research.
Product Specifications
CAS Number
944265-88-7
Smiles
O (C[C@H] (CC (P (=O) (O) O) Br) O) C (CCCCCCCCCCCCCCC) =O.[Na]
Molecular Formula
C20H41BrNaO6P
Molecular Weight
511.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
T-2901-2 2 mg
Texas Red Conjugated Sophora japonica (Pagoda Tree) -SJA-
Sign In for Pricing
View Details 
BNC881574-100 1x 100 µL
HIF1 alpha (Hypoxia-Inducible Factor 1-alpha) (ESEE122), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
